Table 2.
Effects of CPAP therapy on atrial arrhythmia outcomes in OSA patients.
| Author, year | Design | Study population | Diagnostic method | N of patients | Cardiac monitoring | Results |
|---|---|---|---|---|---|---|
| Kanagala et al., 2003 [48] | Observational prospective | Patients underwent AF/AFL DC shock |
PSG | 121 | Hospital records Phone interviews ECG Medical visits |
AF recurrences in 42% of OSA treated with CPAP AF recurrences in 82% of untreated patients |
|
| ||||||
| Abe et al., 2010 [61] | Nonrandomized prospective | Adults underwent PSG study |
PSG | 1456 | ECG monitoring during PSG | CPAP prevented AF, sinus bradycardia/pauses in patients with moderate to severe OSA |
|
| ||||||
| Naruse et al., 2013 [63] | Nonrandomized prospective | Patients underwent PVI isolation |
PSG | 153 | 12-lead ECG 24 h holter ECG Portable ECG monitoring |
Untreated OSA showed higher recurrence of AF after ablation |
|
| ||||||
| Koehler et al., 1998 [69] | Nonrandomized prospective | OSA patients with bradyarrhythmia | PSG | 16 | ECG monitoring during PSG |
CPAP and BPAP drastically decreased bradyarrhythmias |
|
| ||||||
| Simantirakis et al., 2004 [40] | Observational prospective | Moderate-severe OSA | PSG | 23 | Implantable loop recorder | Long-term CPAP therapy completely abolished bradycardia episodes |
AF: atrial fibrillation; AFL: atrial flutter; CPAP: continuous positive airway pressure; OSA: obstructive sleep apnea; PSG: polysomnography; PVI: pulmonary vein isolation.